CTLA4 and lymphedema: Inspired by the encouraging results of the retrospective patient cohort analysis as well as the increased presence of CTLA4+ cells in lymphedema patients, we investigated the anti-CTLA4 treatment in the well-established murine-tail lymphedema model.